Neumora insider plans $110K sale of 69K shares

Neumora Therapeutics, Inc. (NMRA) insider Aurora Daljit Singh filed a notice to sell common stock under Rule 144.

Rhea-AI Filing Summary

Neumora Therapeutics, Inc. (NMRA) insider Aurora Daljit Singh filed a notice to sell common stock under Rule 144. The filing covers a proposed sale of 69,149 shares of common stock through Merrill Lynch in a broker assisted cashless sale, with an aggregate market value of $109,621.88, based on 187,895,912 shares outstanding, with an approximate sale date of 08/18/2026. The shares are to be sold in connection with the exercise of employee stock options, and Singh previously sold 146,706 shares on 08/17/2026 for $220,135.18.

Key Figures

Shares to be sold: 69,149 shares Aggregate market value of planned sale: $109,621.88 Shares outstanding: 187,895,912 shares +3 more

6 metrics

Shares to be sold 69,149 shares Common stock to be sold under Rule 144 via Merrill Lynch

Aggregate market value of planned sale $109,621.88 Aggregate market value of 69,149 shares to be sold

Shares outstanding 187,895,912 shares Number of Neumora Therapeutics, Inc. common shares outstanding

Past 3 months shares sold 146,706 shares Common stock sold on 08/17/2026 by Aurora Daljit Singh

Proceeds from past sale $220,135.18 Value of NMRA shares sold on 08/17/2026

Approximate sale date 08/18/2026 Planned sale date for Rule 144 broker assisted cashless sale

Key Terms

Rule 144, broker assisted cashless sale, Aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

broker assisted cashless sale financial

"Broker assisted cashless sale"

Aggregate market value financial

"69149 | 109621.88 | 187895912"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing by NMRA insider Aurora Daljit Singh disclose?

The filing discloses that Aurora Daljit Singh plans to sell 69,149 shares of Neumora Therapeutics, Inc. (NMRA) common stock under Rule 144 following the exercise of employee stock options via a broker assisted cashless sale on 08/18/2026.

How many NMRA shares are planned to be sold and what is the aggregate market value?

The notice covers a proposed sale of 69,149 shares of NMRA common stock with an aggregate market value of $109,621.88. These figures come from the Rule 144 securities information section detailing the amount to be sold and its corresponding market value.

What is the planned method and date of sale for the NMRA shares in this Form 144?

The shares are expected to be sold on or about 08/18/2026 through Merrill Lynch in a broker assisted cashless sale. This method is tied to the exercise of employee stock options in Neumora Therapeutics, Inc. common stock.

How many Neumora Therapeutics (NMRA) shares are reported as outstanding in this notice?

The Form 144 lists 187,895,912 shares of Neumora Therapeutics, Inc. common stock as outstanding. This figure appears in the securities information section and serves as a reference baseline for the issuer’s total common shares.

What NMRA share sales has Aurora Daljit Singh made in the past three months?

The filing reports that on 08/17/2026, Aurora Daljit Singh sold 146,706 shares of NMRA common stock for $220,135.18. This disclosure appears in the section detailing securities sold during the past 3 months under Rule 144.

Which broker is handling the planned NMRA Rule 144 sale for Aurora Daljit Singh?

The planned Rule 144 sale of Neumora Therapeutics, Inc. (NMRA) shares will be handled by Merrill Lynch, located at 225 Liberty Street, Floor 37, New York, NY 10281. Merrill Lynch is listed as the broker in the securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 04:32 PM EDT Accepted by SEC EDGAR 08/18/2026 - 04:32 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001793971
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Neumora Therapeutics, Inc.
SEC File Number	001-41802
Address of Issuer	260 ARSENAL PLACE, SUITE 1 WATERTOWN MASSACHUSETTS 02472
Phone	(857) 760-0900
Name of Person for Whose Account the Securities are To Be Sold	Aurora Daljit Singh
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	69149	109621.88	187895912	08/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2026	Exercise of employee stock options	Neumora Therapeutics, Inc.			69149	08/18/2026	Broker assisted cashless sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Daljit Singh Aurora 260 ARSENAL PLACE, SUITE 1 WATERTOWN MA 02472	Common Stock	08/17/2026	146706	220135.18

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Daljit Singh Aurora
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)